Sale

Atherectomy Devices Market

Global Atherectomy Devices Market Share, Size, Growth, Trends, Forecast: By Type: Directional Atherectomy Systems, Orbital Atherectomy Systems, Photo-ablative (Laser) Atherectomy Systems, Rotational Atherectomy Systems; By Application: Peripheral Vascular Applications, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Atherectomy Devices Market Outlook

The global atherectomy devices market was valued at USD 846.84 million in 2023, driven by the increasing health consciousness among consumers across the globe. The market size is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032 to achieve a value of USD 2,059.74 million by 2032.

 

Atherectomy Devices: Introduction

Atherectomy devices are used to perform atherectomy which is a process of removing atherosclerotic plaque from effected arteries. Atherectomy is effective when it comes to treating both coronary and arterial disease. Atherectomy devices are designed in a way that they could be used to cut, shave, vaporize, or sand the plaques that are present in the arteries.

 

Global Atherectomy Devices Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Atherectomy is a minimally invasive process by which atherosclerosis is being removed from blood vessels. It is quite effective process and also an alternate to angioplasty which is effectively used to treat peripheral artery disease. Atherectomy could be an alternate to angioplasty but there are no studies that says which one is superior out of both the process. Atherectomy is generally performed in such cases where arteries are encountered to be narrowing down due to the accumulation of atherosclerosis which is caused by peripheral artery disease and coronary artery disease.

 

Key Trends in Atherectomy Devices Market

Atherectomy devices are used to cut the plaque out of the walls of artery unlike angioplasty or stents that push the plaque into the wall of vessel. Atherectomy can be used to treat arteries generally, but they could also be used to treat veins and vascular bypass grafts.

 

There are several key trends running in the global atherectomy devices market and some of them includes escalating technological advancements due to which new devices are developing, which would be much more efficient with the capabilities in comparison with current devices that are available in the market. Increased precision would be the major advantage of these newly introducing atherectomy devices. Due to it being a minimally invasive procedure it has already been gaining popularity as people today are getting more aware and interested in minimally invasive procedures rather than choosing traditional procedures. Shorter recovery time and smaller incisions are the prime reason due to which minimally invasive procedures are in trend in this market.

 

Rising prevalence of cardiovascular disease as peripheral and coronary artery disease due to which plaque gets accumulated in the blood vessels results in the blood flow blockage in the blood vessel. Rising geriatric population which is prone of getting these cardiovascular diseases is also expected to contribute to the growth in the market size of atherectomy devices.

 

Atherectomy Devices Market Segmentations

 

Global Atherectomy Devices Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Type

  • Directional Atherectomy Systems
  • Orbital Atherectomy Systems
  • Photo-ablative (Laser) Atherectomy Systems
  • Rotational Atherectomy Systems

 

Market Breakup by Application

  • Peripheral Vascular Applications
  • Cardiovascular Applications
  • Neurovascular Applications

 

Market Breakup by End User

  • Hospitals and Surgical Centres
  • Ambulatory Care Centres
  • Other End Users

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Atherectomy Devices Market Scenario

The market for atherectomy devices is witnessing gradual growth and is expected to continue growing in coming years as well.  These atherectomy devices are used to remove plaque accumulation from blood vessels that has been accumulated on the walls.

 

Global Atherectomy Devices Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The atherectomy devices are in high demand in the market and this demand is driven by several factors such as rising awareness among people about minimally invasive procedures. Additionally, increasing incidence of cardiovascular diseases among geriatric population that has been growing lately and use of advancing technologies in the development of new atherectomy devices has also been major drivers for the market.

 

Atherectomy Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BD
  • Cardinal Health Inc.
  • Koninklijke Philips NV,
  • Medtronic Plc,
  • Terumo Corporation,
  • Avinger,
  • Cardiovascular Systems,
  • Ra Medical Systems

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • End User
  • Region
Breakup by Type
  • Directional Atherectomy Systems
  • Orbital Atherectomy Systems
  • Photo-ablative (Laser) Atherectomy Systems
  • Rotational Atherectomy Systems
Breakup by Application
  • Peripheral Vascular Applications
  • Cardiovascular Applications
  • Neurovascular Applications
Breakup by End User
  • Hospitals and Surgical Centers
  • Ambulatory Care Centers
  • Other End Users
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott Laboratories
  • Boston Scientific Corporation
  • BD
  • Cardinal Health Inc.
  • Koninklijke Philips NV
  • Medtronic Plc
  • Terumo Corporation
  • Avinger
  • Cardiovascular Systems
  • Ra Medical Systems

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Atherectomy Devices Market Overview 

    3.1    Global Atherectomy Devices Market Historical Value (2017-2023)
    3.2    Global Atherectomy Devices Market Forecast Value (2024-2032)
4    Global Atherectomy Devices Market Landscape
    4.1    Atherectomy Devices: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Atherectomy Devices: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
5    Global Atherectomy Devices Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Atherectomy Devices Market Segmentation
    6.1    Global Atherectomy Devices Market by Type
        6.1.1    Market Overview    
        6.1.2    Directional Atherectomy Systems
        6.1.3    Orbital Atherectomy Systems
        6.1.4    Photo-ablative (Laser) Atherectomy Systems
        6.1.5    Rotational Atherectomy Systems 
    6.2    Global Atherectomy Devices Market by Application
        6.2.1    Market Overview
        6.2.2    Peripheral Vascular Applications
        6.2.3    Cardiovascular Applications
        6.2.4    Neurovascular Applications 
    6.3    Global Atherectomy Devices Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals and Surgical Centers
        6.3.3    Ambulatory Care Centers
        6.3.4    Other End Users
    6.4    Global Atherectomy Devices Market by Region
        6.4.1    Market Overview
        6.4.2    North America
        6.4.3    Europe 
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Atherectomy Devices Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Atherectomy Devices Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Atherectomy Devices Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Atherectomy Devices Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Atherectomy Devices Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    Abbott Laboratories  
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications 
    18.2    Boston Scientific Corporation
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    BD 
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Cardinal Health Inc. 
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Koninklijke Philips NV 
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Medtronic Plc
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Terumo Corporation 
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Avinger 
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Cardiovascular Systems 
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Ra Medical Systems 
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
19    Atherectomy Devices - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The atherectomy devices market attained a value of about USD 846.84 million in 2023.

The atherectomy devices market size is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032 and reach a market value of USD 2,059.74 million by 2032.

The rising healthcare infrastructure and the increasing awareness about health among consumers is a key trend driving the growth of the market.

The different types of atherectomy devices in the market includes directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, rotational atherectomy systems.

The device finds wide applications in peripheral vascular, cardiovascular, and neurovascular applications.

The market segment for end user includes hospitals and surgical centres, ambulatory care centres, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key players involved in the market include Abbott Laboratories, Boston Scientific Corporation, BD, Cardinal Health Inc., Koninklijke Philips NV, Medtronic Plc, Terumo Corporation, Avinger, Cardiovascular Systems, and Ra Medical Systems.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER